Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s): RQHTF

Healthcare Medical Devices

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.

TSXV:RHT.H - Post by User

Reliq Health Technologies Inc > thoughts

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Aug 22, 2021 4:41pm

182 Views

Post# 33746496

RE:RE:thoughts

"Contracts" is misleading. There is no obligation on the clients to onboard any patients within any given time frame. Reliq is obligated to provide the service at set pricing. These contracts are more like firm price quotes.

prophetoffacts wrote: "1. short term catalysts have been priced in the current share price"

Not priced in. The biggst catalyst of all is undervaluation. The 200,000 patients is backward looking and pricenowhere neard in. Lisa has essentially said that they are a done deal which mean little should be needed in terms of a discount. There is nothing priced in for more than 200,000 patients despite demand for RHT's technology having reached the auto-catalytic stage and the size of the addressable market. RHT is routinely adding new clients. Lisa said in the interview there is lots of inbound calls. In other words, 200,000 patients is a minumum. Deals at this stage can also be bigger as RHT's resume strengthens. Again demand is now at the auto-catalytic stage. During the interview Lisa also said she was talking with Oppenheimer. The bids and volume on this stock also suggest a new level of interest. Lisa paints an almost perfect picture for what's to come.